BioTelemetry, Inc. (BEAT) was a big mover last session, as its shares surged over 22% on the day. The surge came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the healthcare stock as it is now trading above the volatile price range of $6.88 to $8.74 in the past one-month time frame.
In the last 30 days, the company did not witness any estimate revision and its Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
BioTelemetry currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other better-ranked stocks in the medical sector include Charles River Laboratories International, Inc. (CRL), Covance Inc. (CVD) and Quintiles Transnational Holdings Inc. (Q). All three sport a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment